Overview

Comparing Efficacy and Safety Between Eperisone a BID and a TID Regimen in Acute Low Back Pain Patients

Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
Multi-center Study to Compare Efficacy and Safety between Eperisone a BID and a TID Regimen in Acute Low Back Pain Patients during 7 days.
Phase:
Phase 2
Details
Lead Sponsor:
Hanmi Pharmaceutical Company Limited
Treatments:
Eperisone